A detailed history of Acadian Asset Management LLC transactions in Adagio Therapeutics, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 652,256 shares of ADGI stock, worth $2.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
652,256
Previous 678,706 3.9%
Holding current value
$2.16 Million
Previous $745,000 10.87%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
N/A
-26,450 Reduced 3.9%
652,256 $664,000
Q2 2024

Aug 06, 2024

BUY
N/A
474,301 Added 232.04%
678,706 $745,000
Q1 2024

May 10, 2024

BUY
N/A
204,405 New
204,405 $905,000
Q4 2022

Feb 14, 2023

BUY
$3.08 - $4.05 $175,134 - $230,291
56,862 New
56,862 $85,000

Others Institutions Holding ADGI

About Adagio Therapeutics, Inc.


  • Ticker ADGI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 108,831,000
  • Market Cap $505M
  • Description
  • Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...
More about ADGI
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.